Benzinga

España
Italia
대한민국
日本
Français
Benzinga Edge
Benzinga Research
Benzinga Pro

  • Get Benzinga Pro
  • Data & APIs
  • Events
  • Premarket
  • Advertise
Contribute
España
Italia
대한민국
日本
Français

Benzinga

  • Premium Services
  • Financial News
    Latest
    Earnings
    Guidance
    Dividends
    M&A
    Buybacks
    Interviews
    Management
    Offerings
    IPOs
    Insider Trades
    Biotech/FDA
    Politics
    Healthcare
    Small-Cap
  • Markets
    Pre-Market
    After Hours
    Movers
    ETFs
    Options
    Cryptocurrency
    Commodities
    Bonds
    Futures
    Mining
    Real Estate
    Volatility
  • Ratings
    Analyst Color
    Downgrades
    Upgrades
    Initiations
    Price Target
  • Investing Ideas
    Trade Ideas
    Long Ideas
    Short Ideas
    Technicals
    Analyst Ratings
    Analyst Color
    Latest Rumors
    Whisper Index
    Stock of the Day
    Best Stocks & ETFs
    Best Penny Stocks
    Best S&P 500 ETFs
    Best Swing Trade Stocks
    Best Blue Chip Stocks
    Best High-Volume Penny Stocks
    Best Small Cap ETFs
    Best Stocks to Day Trade
    Best REITs
  • Money
    Investing
    Cryptocurrency
    Mortgage
    Insurance
    Yield
    Personal Finance
    Forex
    Startup Investing
    Real Estate Investing
    Prop Trading
    Credit Cards
    Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Connect With Us
facebookinstagramlinkedintwitteryoutubeblueskymastodon
About Benzinga
  • About Us
  • Careers
  • Advertise
  • Contact Us
Market Resources
  • Advanced Stock Screener Tools
  • Options Trading Chain Analysis
  • Comprehensive Earnings Calendar
  • Dividend Investor Calendar and Alerts
  • Economic Calendar and Market Events
  • IPO Calendar and New Listings
  • Market Outlook and Analysis
  • Wall Street Analyst Ratings and Targets
Trading Tools & Education
  • Benzinga Pro Trading Platform
  • Options Trading Strategies and News
  • Stock Market Trading Ideas and Analysis
  • Technical Analysis Charts and Indicators
  • Fundamental Analysis and Valuation
  • Day Trading Guides and Strategies
  • Live Investor Events
  • Pre-market Stock Analysis and News
  • Cryptocurrency Market Analysis and News
Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

  • Terms & Conditions
  • Do Not Sell My Personal Data/Privacy Policy
  • Disclaimer
  • Service Status
  • Sitemap
© 2026 Benzinga | All Rights Reserved
March 25, 2023 11:46 AM 2 min read

Artificial Womb Facility Could Grow 30,000 Babies A Year: A Solution To Elon Musk's Fears?

by Bibhu Pattnaik Benzinga Staff Senior Writer
Follow

Billionaire Elon Musk has frequently spoken about his concerns about underpopulation. He has mentioned that people should focus on having more babies to resolve the problem of low birth rates and population collapse. 

In 2022, Musk shared how the COVID-19 pandemic has resulted in a lower birth rate instead of the "baby boom" expected due to people being forced to stay indoors.

Now, a birthing facility could answer Musk's concerns about the world's low birth rates. The world's first artificial womb facility, EctoLife, promises to produce customized babies.

Film producer and biotechnologist Hashem Al-Ghaili have created the technology which would allow women who have had their uterus removed to procreate, while also reducing premature births, and combating population declines, reports the Daily Mail. 

Running on renewable energy, the facility plans to house 75 labs, each equipped with up to 400 growth pods or artificial wombs, reports the media outlet. 

The pods are designed to replicate the real-life conditions of the mother's womb and include sensors that monitor the baby's vitals, like a heartbeat, temperature, and oxygen saturation.

EctoLife aims to grow up to 30,000 babies a year inside its birthing pods. 

Also Read: Musk Had Twins With Neuralink Executive Shivon Zilis Through IVF: Report

Al-Ghaili says the concept is based on "50 years of groundbreaking scientific research conducted by researchers worldwide," and such birthing pods could be widespread in "just decades" from now, the Daily Mail reports. 

Al-Ghaili believes that artificial womb facilities could become a reality in 10 years if ethical restrictions are removed, reports the Mirror.

According to the report, an "Elite Package" would allow people to "genetically engineer the embryo before implanting it into the artificial womb." 

Also, parents can select their baby's level of intelligence, height, hair, eye color, physical strength, and skin tone.

Al-Ghaili says, "Every single feature mentioned in the concept is 100 percent science-based and has already been achieved by scientists and engineers".

"The only thing left is building a prototype by combining all the features into a single device", he was quoted as saying by the Mirror.

Al-Ghaili claims the artificial womb facility can "help" countries facing the problem of a declining population, such as Japan, Bulgaria, and South Korea, among others.

"In terms of timeframe, it depends on the ethical guidelines. Right now, research on human embryos is not allowed beyond 14 days. After 14 days, embryos must be destroyed due to ethical concerns", he adds.

Some elements of this story were previously reported by Benzinga and it has been updated.

Photo: Shutterstock

 
Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.


Posted In:
NewsTechElon MuskICYMI
Beat the Market With Our Free Pre-Market Newsletter
Enter your email to get Benzinga's ultimate morning update: The PreMarket Activity Newsletter
Comments
Loading...